Sign up now to have the right to view
50 tenders for free.
Contract Awards
Total 22
contracts
found. 22 contracts are
listing.
Advanced Filters
Deliveries of Special Medical Material for Intervention Cardiology Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
28.03.2022
Medicinal Products Containing Active Ingredients Pazopanib-hydrochloride Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
31.01.2022
Medicinal Products Containing Active Ingredients Ribociclib-succinate Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
31.01.2022
Medicinal Products Containing Active Substituzumab Emtansin Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
31.01.2022
Medicinal Products Containing Active Ingredient Panitumumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing Active Substance Evolokumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing the Active Ingredient Palbociklib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing Active Substance Enzalutamide Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
18.01.2022
Medicinal Products Containing Active Substance Ustekinumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Substance Kobozantinib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Ingredients Oxacilin Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Substance Vedolizumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
26.12.2021
Medicinal Products Containing Active Ingredients Tocilizumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredients Ibroutinib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredients Eltrombopag Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Substance Trametinib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredients Tocilizumab Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021
Medicinal Products Containing Active Ingredient Dabrafenib Czech Republic
Organization:
*****
Language:
English
Country:
Czech Republic
Deadline:
19.12.2021